ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
•06 Sep 2021 13:12

Jinxin Fertility 1H2021: A Clear Picture of the Long Term Potential

Jinxin Fertility's conference call following the 1H2021 results provided a clearer picture of its execution capability and long term growth drivers...

Logo
382 Views
Share
•29 Jul 2021 16:25

Jinxin Fertility: Signs of Policy Tailwind and Valuation Dislocation

We think there's a dislocation of Jinxin Fertilities' share following the sell-off of Chinese stocks due to the policy targeting education...

Logo
319 Views
Share
bullish•Wuxi Biologics
•20 Jul 2021 18:54

Wuxi Biologics Placement - Similar Deal Will Yield Similar Results

Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...

Logo
597 Views
Share
•05 Jul 2021 19:14

Jinxin Fertility (锦欣生殖) Placement -   A Familiar Name by Now and Don't Expect Extravagant Returns

A shareholder of Jinxin Fertility Co Ltd (1951 HK)  is looking to raise US$100m by selling about 42m of shares or about 1.7% of total shares...

Share
•21 Jun 2021 13:03

Jinxin Fertility: Takeaways from Wuhan NDR and Yunnan Acquisition

Jinxin Fertility announced the acquisition of 19.33% indirect economic interest in two Yunnan based hospitals in China and hosted an online NDR in...

Logo
422 Views
Share
x